BlackRock
TMDX icon

BlackRock’s Transmedics TMDX Stock Holding History

BlackRock’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372M Buy
5,596,549
+303,218
+6% +$25.7M 0.01% 1418
2026
Q1 		$526M Sell
5,293,331
-101,901
-2% -$13.3M 0.01% 1068
2025
Q4 		$656M Buy
5,395,232
+63,634
+1% +$7.99M 0.01% 921
2025
Q3 		$598M Buy
5,331,598
+107,952
+2% +$12.6M 0.01% 972
2025
Q2 		$700M Sell
5,223,646
-24,483
-0.5% -$2.69M 0.01% 832
2025
Q1 		$353M Buy
5,248,129
+19,942
+0.4% +$1.37M 0.01% 1245
2024
Q4 		$326M Sell
5,228,187
-79,572
-1% -$7.41M 0.01% 1371
2024
Q3 		$833M Buy
5,307,759
+2,662,201
+101% +$410M 0.02% 734
2024
Q2 		$398M Buy
2,645,558
+121,932
+5% +$14.6M 0.01% 1157
2024
Q1 		$187M Sell
2,523,626
-26,629
-1% -$2.19M ﹤0.01% 1690
2023
Q4 		$201M Buy
2,550,255
+100,925
+4% +$6.09M 0.01% 1642
2023
Q3 		$134M Buy
2,449,330
+139,937
+6% +$10.1M ﹤0.01% 1812
2023
Q2 		$194M Buy
2,309,393
+54,776
+2% +$4.19M 0.01% 1599
2023
Q1 		$171M Sell
2,254,617
-56,088
-2% -$3.88M 0.01% 1664
2022
Q4 		$143M Buy
2,310,705
+112,051
+5% +$5.96M ﹤0.01% 1763
2022
Q3 		$91.8M Buy
2,198,654
+304,600
+16% +$13.2M ﹤0.01% 2021
2022
Q2 		$59.6M Buy
1,894,054
+1,904
+0.1% +$50.8K ﹤0.01% 2366
2022
Q1 		$51M Sell
1,892,150
-8,789
-0.5% -$157K ﹤0.01% 2578
2021
Q4 		$36.4M Buy
1,900,939
+53,571
+3% +$1.34M ﹤0.01% 2886
2021
Q3 		$61.1M Buy
1,847,368
+21,724
+1% +$664K ﹤0.01% 2529
2021
Q2 		$60.6M Sell
1,825,644
-77,852
-4% -$2.16M ﹤0.01% 2571
2021
Q1 		$79M Buy
1,903,496
+334,620
+21% +$10.3M ﹤0.01% 2331
2020
Q4 		$31.2M Buy
1,568,876
+1,280
+0.1% +$18.9K ﹤0.01% 2762
2020
Q3 		$21.6M Buy
1,567,596
+257,082
+20% +$4.4M ﹤0.01% 2816
2020
Q2 		$23.5M Buy
1,310,514
+229,661
+21% +$3.59M ﹤0.01% 2717
2020
Q1 		$13.1M Buy
1,080,853
+222,556
+26% +$3.73M ﹤0.01% 2849
2019
Q4 		$16.3M Buy
858,297
+510,514
+147% +$9.37M ﹤0.01% 2993
2019
Q3 		$8.26M Buy
347,783
+24,398
+8% +$585K ﹤0.01% 3304
2019
Q2 		$9.38M Buy
+323,385
New +$8.83M ﹤0.01% 3285

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock's TMDX Position: Q2 2026 in Review

BlackRock increased its Transmedics (TMDX) stake by 5.7% in Q2 2026, buying an estimated $25.7M and bringing the position to 5,596,549 shares worth $372M. The position accounts for 0.01% of the portfolio, ranked #1418.

BlackRock first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $833M in Q3 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • BlackRock held 5,596,549 shares of Transmedics worth $372M as of Q2 2026.
  • BlackRock bought 303,218 Transmedics shares in Q2 2026, an estimated $25.7M.
  • Transmedics made up 0.01% of BlackRock's portfolio in Q2 2026, its #1418 holding.
  • BlackRock first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • BlackRock's Transmedics position peaked at $833M in Q3 2024.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.